Aetna
Aetna Aetna
Specialty Pharmacy Clinical Policy Bulletins
Aetna Non-Medicare Prescription Drug Plan
Subject: Specialty Quantity Limit Gattex 2245-H P2024

Drug
GATTEX  (teduglutide)


Policy:

I.  PROGRAM DESCRIPTION

The standard limit is designed to allow a quantity sufficient for the most common uses of the medication. If the member’s plan allows a quantity limit exception review for the requested medication, coverage of an additional quantity may be provided up to the exception limit with prior authorization.


II.  COVERED QUANTITIES

  Medication

  Standard Limit

  Exception Limit*

  FDA-recommended dosing

 

  Gattex (teduglutide) 5 mg (10 mg/mL)
  single-dose vial kit

 

  One 30-vial kit per 30 days

 

Two 30-vial kits per 30 days

 

  0.05 mg/kg/day SC once daily

  Renal dose adjustment (eGFR less than
  60 mL/min/1.73m2):
  •  0.025 mg/kg once daily

     *Patients over 75 kg qualify for the exception limit.

 

 


Place of Service:

Outpatient

The above policy is based on the following references:
  1. Gattex [package insert]. Lexington, MA: Takeda Pharmaceuticals America, Inc.; October 2022.
Copyright Aetna Inc. All rights reserved. Pharmacy Clinical Policy Bulletins are developed by Aetna to assist in administering plan benefits and constitute neither offers of coverage nor medical advice. This Clinical Policy Bulletin contains only a partial, general description of plan or program benefits and does not constitute a contract. Aetna does not provide health care services and, therefore, cannot guarantee any results or outcomes. Participating providers are independent contractors in private practice and are neither employees nor agents of Aetna or its affiliates. Treating providers are solely responsible for medical advice and treatment of members. This Clinical Policy Bulletin may be updated and therefore is subject to change.

June 30, 2024
Aetna
Skip Past Footer Links
Company Information   |   Site Map Aetna.com Home   |   Help   |   Contact Us   |   Search
Web Privacy Statement   |   Legal Statement   |   Privacy Notices   |   Member Disclosure

Back to top